Blog
RSS FeedPosted by Michael Wonder on 04 May 2016
Call for patient input on a submission from Teva Pharmaceuticals for reslizumab
4 May 2016 - CADTH has received notice of a pending submission from Teva Pharmaceuticals for reslizumab for use by patients ...
Posted by Michael Wonder on 20 Nov 2015
CADTH calls for patient input on a new submission from GSK for mepolizumab
20 November 2015 - CADTH has received notice of a pending submission from GSK for mepolizumab for use by patients with ...
Posted by Michael Wonder on 06 Oct 2015
CADTH calls for patient input on a resubmission for Xolair
7 October 2015 - CADTH has received notice of a pending resubmission for Xolair (omalizumab) for patients with severe peristent asthma. ...